Titan Medical Inc (TMDIF)

[saveferris]

This is typical biotech hush hush to sneak attack the market and avoid challenges from the status quo and regulatory bodies. If there is nothing to report before required quarterlies and milestone announcements, then there's nothing to report. The lack of investor relations is either intentional to keep things under wraps, or there's no evidence of wrongdoing. Pick your poison, but don't preemptively accuse management. They've got a feasibility prototype, a new endpiece partnership, and are lining up trial locations...and Q4 isn't near yet. Better times are soon for this stock.

If people want weekly announcements and seeking alpha articles, then go buy a silver or software stock where FDA and the ISRG revolving door is nonexistent.